DD Support Board and Research Team

[namtae]

A question may be when and under what conditions were the shares issued to the clinical research firm.

For ex, a cash compensation agreement may have been in place. Then subsequent to the performance of services, the company is unable to make full payment in cash of its outstanding balance and negotiates a settlement in capital shares.

If the deal was for shares in the first place, it would seem to be a conflict of interest, depending on what the services were. Recruitment or study design may be less conflicting than say lead investigator